GSK says vaccine business president to leave by year-end
Roger Connor, president of its global manufacturing and supply division since 2012, would replace Debruyne on September 1. Debruyne has held a number of roles during his career at GlaxoSmithKline, including general manager in the Netherlands and Italy and senior vice president of the company’s pharmaceuticals business in Europe. CEO Emma Walmsley said earlier this year she was increasingly confident the company would be able to drive sales and profit growth over the next few years, helped by newer products such as its successful new shingles vaccine Shingrix.
Source:: https://finance.yahoo.com/news/gsk-says-vaccine-business-president-133846719.html
